lobbying_activities: 2183963

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2183963	4140b7bb-5c51-4ebe-bdd1-88af6743bc1d	Q3	COVINGTON & BURLING LLP	11195	FLEXION THERAPEUTICS, INC.	2018	third_quarter	PHA	Education and support for public policies that promote the development, use, coverage and reimbursement of novel, non-opioid pain therapies, including FDA Opioid Sparing legislation.	HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2018-10-15T10:23:11.977000-04:00